Acton Pharmaceuticals, Inc. Announces Publication of AEROSPAN(R) (Flunisolide ... MarketWatch (press release) Inhaled corticosteroids (ICS) are the preferred long-term therapy for patients with persistent asthma. However, concerns remain about potential effects of long-term ICS use on growth in children. AEROSPAN is a HFA-propelled ICS and is the only approved ... |
